EDGe Surgical Granted U.S. Patent for Next-Generation Awl-in-One Tap

Awl-in-One Tap is a single-use spinal surgery instrument with disposable neuromonitoring EMG system and digital depth measurement built in.

Getinge Expands Servo Ventilator Platform

Getinge announced clearance from the U.S. FDA of several new software options for the Servo-u and Servo-n ventilators.

Merrow Launches Recyclable PPE

Merrow Manufacturing is set to debut a “revolutionary” new line of closed loop, Net Zero PPE, personal protective equipment that includes medical gowns, surgical caps and scrubs woven with REPREVE recycled polyester – made from 100% recycled post-consumer content (plastic bottles).

Lexington Medical Achieves 10,000 Surgery Milestone for Endostapling Devices

Lexington Medical, a U.S.-based medical device company delivering minimally invasive surgical stapling solutions, announced that the company has achieved over 10,000 successful surgeries with the AEON Endostapler in multiple countries.

Diversey Announces Efficacy Testing Against SARS-CoV-2

Diversey, Inc., a global leader in healthcare and infection prevention products and solutions, today announced it will test several of its disinfectant products for efficacy against SARS-CoV-2, which causes COVID-19.  These results will be submitted to the EPA for approval.

“With a mission to protect and care for people every day, infection prevention is a major focus for Diversey,” said Mark Copeland, CMO for Diversey, Inc.  “Up until now, healthcare providers and others have been looking at the EPA’s Emerging Viral Pathogens Program for guidance, and more recently for claims against human coronavirus, on what products may work as disinfectants based on knowledge of similar pathogens. The Emerging Viral Pathogens Program is intended to bridge the gap between when outbreaks occur and novel viruses are available to test for specific product efficacy.”

Diversey has partnered with Microbac Laboratories, Inc. to test several of its products for effectiveness against SARS-CoV-2.  Microbac is a leading testing laboratory that offers antiviral and antimicrobial efficacy testing for various disinfectants, sanitizers, antiseptics, and devices, against SARS, MERS, and other microorganisms. Microbac is one of the only testing laboratories in the world certified by the CDC to test the effectiveness of products against SARS-CoV-2 and viruses like it.

“Protecting the public against SARS-CoV-2 is an all-hands-on-deck issue,” said Trevor Boyce, Microbac’s Chairman and CEO. “We are eager to apply our scientific knowledge and experience to our work with a global leader like Diversey, to develop new tools in the fight against this pandemic.”

“Creating a safer environment for all people, including patients, providers, and the public, is critical in this time, and Diversey is committed to continue to provide products and practices to optimize outcomes,” added Copeland.

This test data will not replace the EPA List N and guidelines for disinfectants for use against SARS-CoV-2 at this time.  All products on this list meet EPA’s criteria for use against SARS-CoV-2, the virus that causes COVID-19.  The testing will provide added assurance for specific efficacy against this virus.  Until there is further EPA guidance, disinfectants found on the EPA’s List N should continue to be used according to their label instructions.

The following Diversey products can be found on List N:



Submit a Comment

Your email address will not be published. Required fields are marked *